These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35990649)

  • 1. Corrigendum: Brief Research Report: Virus-Specific Humoral Immunity at Admission Predicts the Development of Respiratory Failure in Unvaccinated SARS-CoV-2 Patients.
    Tajuelo A; Carretero O; García-Ríos E; López-Siles M; Cano O; Vázquez M; Más V; Rodríguez-Goncer I; Lalueza A; López-Medrano F; San Juan R; Fernández-Ruiz M; Aguado JM; McConnell MJ; Pérez-Romero P
    Front Immunol; 2022; 13():965809. PubMed ID: 35990649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brief Research Report: Virus-Specific Humoral Immunity at Admission Predicts the Development of Respiratory Failure in Unvaccinated SARS-CoV-2 Patients.
    Tajuelo A; Carretero O; García-Ríos E; López-Siles M; Cano O; Vázquez M; Más V; Rodríguez-Goncer I; Lalueza A; López-Medrano F; Juan RS; Fernández-Ruiz M; Aguado JM; McConnell MJ; Pérez-Romero P
    Front Immunol; 2022; 13():878812. PubMed ID: 35547738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Humoral immunity against SARS-CoV-2 in workers of social health care centers of Castilla y León after vaccination with the BNT162b2 mRNA vaccine from Pfizer/Biontech.].
    Casas Fischer R
    Rev Esp Salud Publica; 2021 Oct; 95():. PubMed ID: 34690347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immune responses in hospitalized COVID-19 patients.
    Mahallawi WH
    Saudi J Biol Sci; 2021 Jul; 28(7):4055-4061. PubMed ID: 33935561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term SARS-CoV-2 Specific Immunity Is Affected by the Severity of Initial COVID-19 and Patient Age.
    Konik M; Lindemann M; Zettler M; Meller L; Dolff S; Rebmann V; Horn PA; Dittmer U; Krawczyk A; Schipper L; Trilling M; Anastasiou OE; Schwarzkopf S; Thümmler L; Taube C; Schöbel C; Brenner T; Skoda EM; Wilde B; Gäckler A; Witzke O; Rohn H
    J Clin Med; 2021 Oct; 10(19):. PubMed ID: 34640623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigation of SARS-CoV-2-Specific Humoral and Cellular Immunity Values in Health Care Workers with COVID-19 Disease and Administered with COVID-19 Vaccine].
    Keskin AÜ; Dalan AB; Çıragil P; Topkaya AE
    Mikrobiyol Bul; 2022 Jul; 56(3):480-492. PubMed ID: 35960239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring Specific IgM and IgG Production Among Severe COVID-19 Patients Using Qualitative and Quantitative Immunodiagnostic Assays: A Retrospective Cohort Study.
    Al-Mughales JA; Al-Mughales TJ; Saadah OI
    Front Immunol; 2021; 12():705441. PubMed ID: 34539635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study.
    Lampasona V; Secchi M; Scavini M; Bazzigaluppi E; Brigatti C; Marzinotto I; Davalli A; Caretto A; Laurenzi A; Martinenghi S; Molinari C; Vitali G; Di Filippo L; Mercalli A; Melzi R; Tresoldi C; Rovere-Querini P; Landoni G; Ciceri F; Bosi E; Piemonti L
    Diabetologia; 2020 Dec; 63(12):2548-2558. PubMed ID: 33029657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum: Cross-reactive humoral and CD4
    Martel F; Cuervo-Rojas J; Ángel J; Ariza B; González JM; Ramírez-Santana C; Acosta-Ampudia Y; Murcia-Soriano L; Montoya N; Cardozo-Romero CC; Valderrama-Beltrán SL; Cepeda M; Castellanos JC; Gómez-Restrepo C; Perdomo-Celis F; Gazquez A; Dickson A; Brien JD; Mateus J; Grifoni A; Sette A; Weiskopf D; Franco MA
    Front Immunol; 2023; 14():1274753. PubMed ID: 37662943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test.
    Kitagawa Y; Imai K; Matsuoka M; Fukada A; Kubota K; Sato M; Takada T; Noguchi S; Tarumoto N; Maesaki S; Takeuchi S; Maeda T
    J Med Virol; 2022 Jan; 94(1):335-341. PubMed ID: 34524695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum: Case report: Persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID.
    Goh D; Lim JCT; Fernaíndez SB; Joseph CR; Edwards SG; Neo ZW; Lee JN; Caballero SG; Lau MC; Yeong JPS
    Front Immunol; 2022; 13():1036894. PubMed ID: 36275692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 recombinant proteins stimulate distinct cellular and humoral immune response profiles in samples from COVID-19 convalescent patients.
    Silva LTD; Ortega MM; Tiyo BT; Viana IFT; Lima TE; Tozetto-Mendoza TR; Oliveira LMDS; Teixeira FME; Lins RD; Almeida A; Mendes-Correa MC; Duarte AJDS; Oshiro TM
    Clinics (Sao Paulo); 2021; 76():e3548. PubMed ID: 34878034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 in multiple-myeloma patients: cellular and humoral immunity against SARS-CoV-2 in a short- and long-term view.
    von Metzler I; Campe J; Huenecke S; Raab MS; Goldschmidt H; Schubert R; Rabenau HF; Ciesek S; Serve H; Ullrich E
    J Mol Med (Berl); 2022 Mar; 100(3):463-470. PubMed ID: 34657968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustainability of SARS-CoV-2 Induced Humoral Immune Responses in COVID-19 Patients from Hospitalization to Convalescence Over Six Months.
    Zheng Y; Zhang Q; Ali A; Li K; Shao N; Zhou X; Ye Z; Chen X; Cao S; Cui J; Zhou J; Wang D; Hou B; Li M; Cui M; Deng L; Sun X; Zhang Q; Yang Q; Li Y; Wang H; Lei Y; Yu B; Cheng Y; Tong X; Men D; Zhang XE
    Virol Sin; 2021 Oct; 36(5):869-878. PubMed ID: 33661489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral, Cellular and Cytokine Immune Responses Against SARS-CoV-2 Variants in COVID-19 Convalescent and Confirmed Patients With Different Disease Severities.
    Chiu CH; Chang YH; Chang FY; Hung YJ; Liao CL; Chiu KC; Tsai PL; Chang TW; Yen LC
    Front Cell Infect Microbiol; 2022; 12():862656. PubMed ID: 35656028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preexisting Humoral Immunity Cross-Reacting with SARS-CoV-2 Might Prevent Death Due to COVID-19 in Critical Patients.
    Yamashita T; Shimakami T; Nio K; Terashima T; Okajima M; Taniguchi T; Wada T; Honda M; Gabata T; Ota K; Yanagihara K; Kaneko S
    J Clin Med; 2022 Jul; 11(13):. PubMed ID: 35807155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic landscape mapping of humoral immunity to SARS-CoV-2 identifies non-structural protein antibodies associated with the survival of critical COVID-19 patients.
    Cheng L; Zhang X; Chen Y; Wang D; Zhang D; Yan S; Wang H; Xiao M; Liang T; Li H; Xu M; Hou X; Dai J; Wu X; Li M; Lu M; Wu D; Tian R; Zhao J; Zhang Y; Cao W; Wang J; Yan X; Zhou X; Liu Z; Xu Y; He F; Li Y; Yu X; Zhang S
    Signal Transduct Target Ther; 2021 Aug; 6(1):304. PubMed ID: 34404759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratum: Detailed Multiplex Analysis of SARS-CoV-2 Specific Antibodies in COVID-19 Disease.
    Frontiers Production Office
    Front Immunol; 2021; 12():733897. PubMed ID: 34326851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Levels of Peripheral CD3
    Aljabr W; Al-Amari A; Abbas B; Karkashan A; Alamri S; Alnamnakani M; Al-Qahtani A
    Microbiol Spectr; 2022 Feb; 10(1):e0084521. PubMed ID: 35196808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.